Close Menu
Home › Biocartis Receives FDA Clearance for Viral Detection Panel

Biocartis Receives FDA Clearance for Viral Detection Panel

Sep 05, 2017

NEW YORK (GenomeWeb) – Biocartis announced today that its Idylla Respiratory Panel (IFV-RSV) has been granted 510(k) clearance by the US Food and Drug Administration. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
27
Featured Webinar

How One NGS Core Lab Reduced Sequencing Costs with a Novel Library Normalization Kit

Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Apr
09
Featured Webinar

Combining AI with Community-Driven Insights: Advanced Diagnosis of Inherited Cardiac Diseases

Sponsored by
Sophia Genetics

This webinar will present the utility of a personalized in silico analytical approach for the routine clinical diagnosis of channelopathies and cardiomyopathies. 

Apr
30
Featured Webinar

Novel Methods for Improving De Novo Transcriptome Annotation with Long-Read Transcript Sequencing

Sponsored by
Lexogen

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

What's Popular?

In Infectious Disease

  1. Bruker TB Test, PCR Platform Receives CE-IVD Mark

  2. Curetis, Menarini Diagnostics Ink Strategic Distribution Agreement for Curetis MDx System

  3. Abbott Receives CE Mark for Alinity Molecular Diagnostics System, Assays

  4. GenePOC Strep A Test Granted FDA Clearance

  5. Proteomic Test to Diagnose, Differentiate Zika, Dengue Developed by A*STAR Team

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.